The 2 references without contexts in paper K. Mukhin Yu., O. Pylaeva A., К. Мухин Ю., О. Пылаева А. (2015) “Применение перампанела (Файкомпы) в лечении эпилепсии (опыт Института детской неврологии и эпилепсии им. Святителя Луки) // PERAMPANEL (FYCOMPA) FOR TREATMENT OF EPILEPSY (EXPERIENCE OF THE SVT. LUKA'S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)” / spz:neicon:rjdn:y:2014:i:4:p:14-19

1
Ryvlin P. et al. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia 2013;54(8):1481–9. 26. Zwart R., Sher E., Ping X. et al.
(check this in PDF content)
2
Perampanel, an аntagonist of α-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid receptors for the treatment of epilepsy: studies in human epileptic brain, nonepil
(check this in PDF content)